Guidance

Diphtheria, tetanus and inactivated poliomyelitis vaccine: patient group direction template

Patient group direction (PGD) template to support the national diphtheria, tetanus and inactivated poliomyelitis (Td/IPV – Revaxis®) vaccination programme.

From:
UK Health Security Agency
Published
6 November 2015
Last updated
810 AugustJuly 20222024 — See all updates

Applies to England

Documents

Diphtheria, tetanus and inactivated poliomyelitis vaccine (Td/IPV – Revaxis®): patient group direction (PGD) template

Ref: UKHSA publications gateway number: GOV-12925 GOV-16527

MS Word Document, 127250 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.ukpublications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This PGD template supports the administration of diphtheria, tetanus and inactivated poliomyelitis vaccine (Td/IPV), to individuals from 10 years of age, in accordance with national immunisation programme, for travel or for the management of cases and contacts of diphtheria, tetanus or poliomyelitis.

Td/IPV (Revaxis®) PGD v05.00version 6.00 is valid from 54 August 20222024 to 4 August 2024.2026.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy and procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and summary of product characteristics for the vaccine.

Published 6 November 2015
Last updated 810 AugustJuly 20222024 + show all updates

  1. Added version 6.00 – see page 3 for change history.

  2. Added version 05.00 – see page 2 for change history.

  3. Added v04.00 – see page 2 for change history.

  4. Added Diphtheria, tetanus and inactivated poliomyelitis vaccine patient group direction (PGD) template.

  5. Reviewed and updated to add management of cases and contacts.